Alteration in cellular immunity after chronic hepatitis b deteriorated into severe hepatitis and its significance

Hepatitis Monthly

Volumn 11, Issue 10, 2011, Pages 810-815

  Xibing, Gu ^a   Xiaojuan, Yang ^a   Zhonghua, Lu ^a   Juanhua, Wang ^a  

^a Wuxi Hospital for Infectious Diseases   (China)

Author keywords

Chronic; Hepatitis B; Killer cells; Natural; T lymphocytes

Indexed keywords

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CHRONIC HEPATITIS B; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL;

EID: 80355139422     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.1756     Document Type: Article

References (17)

1. Menne S, Roneker CA, Roggendorf M, Gerin JL, Cote PJ, Tennant BC. Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J Virol. 2002;76(4):1769-1780.
2. Society of Infectious and Parasitologic Diseases and Society of Hepatology CMA. [Chinese medicine national program for prevention and treatment of viral hepatitis]. Chin J Hepatol. 2000;8:324-325.
3. Chen Y, Li L. [Advances in research of cell immune responses of specific cytotoxic T lymphocytes in hepatitis B virus infection]. Foreign Med Sci Epidemiol Lemol 2004;31:27-30.
4. Bathgate AJ, Garden OJ, Forsythe JR, Madhaven KK, Finlayson ND, Simpson KJ, et al. The outcome of the first 165 orthotopic liver transplants in Scotland. Scott Med J. 1999;44(1):9-10.
5. Bektas M, Idilman R, Soykan I, Soydan E, Arat M, Cinar K, et al. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. J Clin Gastroenterol. 2008;42(5):517-521.
6. Jumei C, Zhengsheng Z. [Prevention and control of hepatic failure in patients with severe hepatitis B]. Infect Dis Information. 2088;21(2):65-67.
7. Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 1990;248(4953):361-364.
8. Ando K, Moriyama T, Guidotti LG, Wirth S, Schreiber RD, Schlicht HJ, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 1993;178(5):1541-1554.
9. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29-60.
10. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med. 2000;191(8):1263-1268.
11. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003;38(1):4-13.
12. Hong D, Yutian C, Xiaoyan H, Fucheng Z, XiaoMmou P, Zhiliang G, et al. Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients. Chin J Hepatol. 2006;14(10):271-275.
13. Gu X, Yang X, Wang D, Hua Z, Wu H, Chen H, et al. Comparison and significance of specific and non-specific cellular immunity in patients with chronic hepatitis B caused by infection with genotypes B or C of hepatitis B virus. Sci China C Life Sci. 2009;52(8):719-723.
14. Xi-bing G, Xiao-juan S, Dong Y, Zhong H, Yue-qin X, Zhong-hua L. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B. Chin Med J. 2009;122(18): 2129-2132.
15. Onji M, Doi Y, Miyaoka H, Masumoto T, Horiike N, Ohta Y. Serum levels of soluble CD4 and CD8 in patients with chronic viral hepatitis. Hepatogastroenterology. 1994;41(4):377-379.
16. Jie Q, Qiqiang L, Yanhong F, Yongcheng Z, Shaofeng Z. Changes in peripheral blood lymphocytes in patients with hepatitis B. Pract J Hepatol. 2010;13(3):178-179.
17. Xibing G, Haokun C, Haisu L, Yinfan Z, Hong C, Hao P. Research on sequential treatment of severe hepatitis with corticosteroids and Qianglining. Chin J Hepatol. 2001;9(6):342.